Grantable
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
up to $47,500,000 May 4, 2026
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or onc…
Ask me anything about applying to this grant — your fit, eligibility, or how to start your narrative.
One free message · powered by Grantable AI
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.